Ironwood Pharmaceuticals (IRWD) Change in Accured Expenses (2010 - 2026)

Ironwood Pharmaceuticals (IRWD) has 17 years of Change in Accured Expenses data on file, last reported at -$219000.0 in Q1 2026.

• For the quarter ending Q1 2026, Change in Accured Expenses fell 217.11% year-over-year to -$219000.0; the trailing twelve-month figure through Mar 2026 stood at $3.6 million (up 116.79% YoY), and the FY2025 full-year result was $4.0 million, up 119.62% from the prior year.
• Change in Accured Expenses grew to -$219000.0 in Q1 2026, from -$2.6 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $16.9 million in Q4 2022 to a low of -$15.7 million in Q2 2024.
• A 5-year average of -$301882.4 and a median of -$219000.0 in 2026 frame the typical range for Change in Accured Expenses.
• Across the five-year window, Change in Accured Expenses tumbled 5251.13% in 2022 and jumped 15397.1% in 2025, its largest moves.
• Tracing IRWD's Change in Accured Expenses over 5 years: stood at $16.9 million in 2022, then slumped by 117.75% to -$3.0 million in 2023, then slumped by 91.35% to -$5.8 million in 2024, then surged by 55.58% to -$2.6 million in 2025, then surged by 91.43% to -$219000.0 in 2026.
• Business Quant data shows IRWD's Change in Accured Expenses at -$219000.0 in Q1 2026, -$2.6 million in Q4 2025, and $10.7 million in Q3 2025.